按潜在通路靶点分类

Life Chemicals has developed its RNA Screening Library of over 4,400 drug-like compounds with predicted RNA-binding activity as an excellent starting point for post-transcriptional gene regulation, antibacterial, and antiviral drug discovery research.

Life Chemicals has designed a library of potential GPCR modulators based on known structure and activity data for GPCR targeting compounds available publicly.

Cysteine Protease Focused Library comprises over 3,700 screening compounds with potential inhibitory activity against cysteine proteases.

ATP酶靶向库，其中包含超过13,500个类似药物的筛选化合物。

Over 2,500 screening compounds of potential helicase inhibitors were selected, with the most active compounds placed at the top of the list.

ChemDiv开发了RNA等位三核苷酸模拟物库，该化合物库包含29000个小分子化合物，专门用于靶向RNA 扩展重复序列。

ChemDiv’s RNA-Protein Interaction Inhibitors Library contains 2,111 compounds.

含2.1万种潜在活性小分子化合物，是表观转录组学、免疫系统和中枢神经系统疾病相关研究的有力工具。

Life Chemicals has designed a new Tyrosine Kinase Screening Library of about 5,700 drug-like screening compounds offered for high throughput screening (HTS).

Serine proteases are one of the most biologically important families of proteins that have been shown to play multifarious roles in various diseases (such as cancer proliferation, auto-immune disorders, and allergy).

Over 17,000 structurally diverse molecules with potential polymerase inhibition activity.

The Matrix Metalloproteinase Focused Library contains over 2,000 screening compounds.

Life Chemicals offers its new Chelator Library (over 5,700 compounds) that is based on a variety of metal-binding groups.

The total number of compounds in the Aurora B Kinase Targeted Library is about 1,000.

OTAVAchemicals offers Transporter Modulators Library (525 compounds).

利用我们在合成trans-十氢萘相关的多氧骨架方面的努力，我们开发了一个非含氮化合物库，用于筛选传统上需要碱性化合物的GPCR靶点。

ChemDiv’s PTPs-targeted library contains 15,000 compounds and design at CDL involves:

OTAVAchemicals offers a high-quality PDZ Domain Targeted Library.

激酶ATP位点结合剂筛选库包含24000个化合物，旨在发现新型激酶ATP 口袋结合物。

We offer SARS-CoV-2 Endoribonuclease (NSP15) Targeted Library, which contains 626 compounds.

OTAVAchemicals 11β-HSD1 Targeted Library (924 compounds) has been designed with flexible molecular docking.

ChemDiv’s Proline Kinase Library contains 2,000 compounds.

ChemDiv’s Autophagy-Targeted Library contains 4,550 compounds.

OTAVAchemicals offers Enhancer of Zeste Homolog 2 (EZH2) Targeted Library. It contains 979 compounds with predicted inhibitory activity against this enzyme.

iPPI Bayesian Library with 2637 compounds was prepared using Bayesian modeling (ECFP6 and FCFP6 fingerprints) based on known active PPI inhibitors (IC50<100 nM) taken from the TIMBAL database.

OTAVAchemicals offers SARS-CoV-2 RNA-dependent RNA Polymerase (RdRp) Targeted Library, which contains 1031 compounds with predicted activity against SARS-CoV-2 RdRp.

ChemDiv’s Antimitotic Tubulin Library contains 18,000 compounds.

Mitogen-activated protein kinase 1 (MAPK1 ERK2) inhibitor library contains 197 compounds.

ChemDiv designed a novel library of 5000 compounds

冠状病毒筛选库包含2019-nCoV主要蛋白酶靶向库、eEF1A靶向库、2019-nCoV木瓜样蛋白酶靶向库、SARS冠状病毒重点库

Life Chemicals has designed its Caspase Targeted Library using docking-based virtual screening. Caspase Targeted Library contains 2800 compounds.

The Life Chemicals Receptor-based Screening Library contains over 2,000 potential lysine-specific demethylase 4A (KDM4A) inhibitors selected with computational chemistry and virtual screening techniques. The Library presented is a rich source of inhibitors for screening projects in KDM-related drug discovery.

Life Chemicals has designed a Library of over 3,900 drug-like screening compounds that are small-molecule analogs of known ligase inhibitors with experimentally determined activity.

We have designed an MDM2-targeted library of more than 23K small molecule compounds.

ChemDiv’s Protein Kinases Inhibitors Library contains 38,000 compounds.

Estrogen receptor β (ERβ) antagonist library in Otava contains 464 compounds.